- Meeting abstract
- Open Access
25Hydroxy-vitamin D status in patients with berardinelli-seip syndrome (congenital generalized lipodystrophy)
- Lia Beatriz de Azevedo Souza Karbage1,
- Ana Paula Dias Rangel Montenegro1,
- Luciana Felipe Férrer Aragão1,
- Izabella Tamira Galdino Farias Vasconcelos1,
- Virgínia Oliveira Fernandes1,
- Annelise Barreto de Carvalho1,
- Clarisse Mourão Melo Ponte1,
- Catarina Brasil D'Alva1,
- Carla Soraya Costa Maia1,
- Synara Cavalcante Lopes1,
- Marivaldo Loyola Aragão1,
- Carla Antoniana Ferreira de Almeida Vieira1Email author,
- Ana Paula Germano Lopes Cavalcante1 and
- Renan Magalhães MontenegroJunior1
© de Azevedo Souza Karbage et al. 2015
- Published: 11 November 2015
- Hepatic Steatosis
- Autosomal Recessive Disease
- Decrease Insulin Sensitivity
- Literature Description
Low status of 25-hydroxyvitamin D [25(OH)D] is defined as level< 30ng/mL. Studies indicate high prevalence of hypovitaminosis D at different ages in many regions of Brazil. It is associated with decreased insulin sensitivity and reduced pancreatic β-cell function. Berardinelli-Seip Syndrome (BS) is a rare congenital autosomal recessive disease due to mutations in 4 main genes (AGPAT2, BSCL2, CAV1 and PTRF). It presents lack of metabolically active fat, and ectopic adipose storage in liver and skeletal muscle, impaired metabolism of lipids and carbohydrates, insulin resistance, diabetes mellitus (DM) and dyslipidemia. We did not find in the literature descriptions about levels of 25(OH)D in groups of patients with BS.
To describe 25(OH)D blood levels and its correlation with insulin, glycosylated hemoglobin (A1c), HOMA-IR and hepatic steatosis in patients.
Cross-sectional study conducted between 2013 and 2014. We evaluated 13 patients with BS followed at a University Hospital. Blood dosage of 25(OH)D, insulin, A1c, HOMA-IR, abdominal ultrasound and genetic study was made. Associations were tested by Spearman's rank correlaction coefficient.
The results were expressed as median, 25th percentile and 75th percentile for 25(OH)D levels, mean and standard deviation for other laboratory tests, and absolute frequency for the other variables. The median of 25(OH)D was 36.3 (26.3 – 40.5) ng/mL. Nine patients presented normal levels of 25(OH)D, with median of 40.5 (36.3-42.1) ng/mL, 2 presented insufficiency (26 ng/mL) and 2 presented deficiency (18.2 ng/mL). Among other variables, 6 patients had DM, 12 hepatomegaly and 4 hepatic steatosis. All patients had severe low leptin levels (1.2±0.3 ng/mL). Four patients showed mutation on AGPAT2 gene, and 6 on BSCL2. The genetic study of 3 patients is in progress. The correlation coefficients between 25(OH)D levels and insulin, A1c, HOMA-IR, DM, and hepatic steatosis were not significant.
In this study there was an unexpected predominance of normal levels of 25(OH)D in patients with BS, which is not an usual finding in Brazilian population nowadays. Some authors hypothesize that high leptin levels impairs the synthesis of 25(OH)D in obese. It may suggest a possible role of leptin deficiency in the 25(OH)D sufficiency in BS. Another hypothesis are that excess of subcutaneous fat would sequester vitamin D and that hepatic injury would result in low 25(OH)D synthesis.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.